Tag archive for ‘a potential therapy for Covid-19’
By editor3 On Tuesday, May 12th, 2020

Jubilant Life Sciences Limited enters into Licensing Agreement with Gilead for Remdesivir, a potential therapy for Covid-19

Noida, Tuesday, May 13, 2020. Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, is pleased to announce that its subsidiary, Jubilant Generics Limited (“Jubilant”), More...

Live Updates COVID-19 CASES